- Home
- EVTL vs GNLX Comparison
EVTL vs GNLX Comparison
Compare EVTL & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVTL
- GNLX
- Stock Information
- Founded
- EVTL 2016
- GNLX 2001
- Country
- EVTL United Kingdom
- GNLX United States
- Employees
- EVTL N/A
- GNLX N/A
- Industry
- EVTL Aerospace
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- EVTL Industrials
- GNLX Health Care
- Exchange
- EVTL Nasdaq
- GNLX Nasdaq
- Market Cap
- EVTL 444.1M
- GNLX 128.0M
- IPO Year
- EVTL N/A
- GNLX 2023
- Fundamental
- Price
- EVTL $5.35
- GNLX $3.92
- Analyst Decision
- EVTL Strong Buy
- GNLX Strong Buy
- Analyst Count
- EVTL 7
- GNLX 4
- Target Price
- EVTL $10.83
- GNLX $17.75
- AVG Volume (30 Days)
- EVTL 911.6K
- GNLX 132.9K
- Earning Date
- EVTL 08-05-2025
- GNLX 11-13-2025
- Dividend Yield
- EVTL N/A
- GNLX N/A
- EPS Growth
- EVTL N/A
- GNLX N/A
- EPS
- EVTL N/A
- GNLX N/A
- Revenue
- EVTL N/A
- GNLX N/A
- Revenue This Year
- EVTL N/A
- GNLX N/A
- Revenue Next Year
- EVTL N/A
- GNLX N/A
- P/E Ratio
- EVTL N/A
- GNLX N/A
- Revenue Growth
- EVTL N/A
- GNLX N/A
- 52 Week Low
- EVTL $2.76
- GNLX $1.95
- 52 Week High
- EVTL $15.99
- GNLX $5.89
- Technical
- Relative Strength Index (RSI)
- EVTL 54.92
- GNLX 62.72
- Support Level
- EVTL $4.90
- GNLX $3.56
- Resistance Level
- EVTL $5.17
- GNLX $3.61
- Average True Range (ATR)
- EVTL 0.30
- GNLX 0.23
- MACD
- EVTL 0.10
- GNLX 0.04
- Stochastic Oscillator
- EVTL 83.90
- GNLX 88.57
About EVTL Vertical Aerospace Ltd.
Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero operating emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.